Skip to main content
Article thumbnail
Location of Repository

Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group

By Chingching Foocharoen, Alan Tyndall, Eric Hachulla, Edoardo Rosato, Yannick Allanore, Dominique Farge-Bancel, Paola Caramaschi, Paolo Airó, Starovojtova M. Nikolaevna, José A. Pereira da Silva, Bojana Stamenkovic, Gabriela Riemekasten, Simona Rednic, Jean Sibilia, Piotr Wiland, Ingo Tarner, Vanessa Smith, Anna Theresa Onken, Walid A. Abdel Atty Mohamed, Oliver Distler, Jadranka Morović-Vergles, Andrea Himsel, Paloma G. de la Peña Lefebvre, Thomas Hügle and Ulrich A. Walker


Introduction: Erectile dysfunction (ED) is common in men with systemic sclerosis (SSc) but the demographics, risk factors and treatment coverage for ED are not well known.\ud \ud Method: This study was carried out prospectively in the multinational EULAR Scleroderma Trial and Research database by amending the electronic data-entry system with the International Index of Erectile Function-5 and items related to ED risk factors and treatment. Centres participating in this EULAR Scleroderma Trial and Research substudy were asked to recruit patients consecutively.\ud \ud Results: Of the 130 men studied, only 23 (17.7%) had a normal International Index of Erectile Function-5 score. Thirty-eight per cent of all participants had severe ED (International Index of Erectile Function-5 score ≤ 7). Men with ED were significantly older than subjects without ED (54.8 years vs. 43.3 years, P < 0.001) and more frequently had simultaneous non-SSc-related risk factors such as alcohol consumption. In 82% of SSc patients, the onset of ED was after the manifestation of the first non-Raynaud's symptom (median delay 4.1 years). ED was associated with severe cutaneous, muscular or renal involvement of SSc, elevated pulmonary pressures and restrictive lung disease. ED was treated in only 27.8% of men. The most common treatment was sildenafil, whose efficacy is not established in ED of SSc patients.\ud \ud Conclusions: Severe ED is a common and early problem in men with SSc. Physicians should address modifiable risk factors actively. More research into the pathophysiology, longitudinal development, treatment and psychosocial impact of ED is needed

Topics: ddc:610
Year: 2012
OAI identifier:

Suggested articles


  1. (2010). A: The effect of nondipper pattern of hypertension on erectile dysfunction.
  2. (2008). Al-Ansari A: Prevalence of erectile dysfunction in male stroke patients, and associated co-morbidities and risk factors. Int Urol Nephrol
  3. (1999). BM: Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction.
  4. (2007). Clinical practice. Erectile dysfunction.
  5. (2007). Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis
  6. (2005). Coltman CA: Erectile dysfunction and subsequent cardiovascular disease. JAMA
  7. (2007). D: The prevalence of erectile dysfunction among hypertensive and prehypertensive men aged 25-40 years.
  8. (1995). de las MA, Goldstein I: Systemic sclerosis and impotence: a clinicopathological correlation.
  9. (2008). Diagnosis and management of scleroderma peripheral vascular disease. Rheum Dis Clin North Am
  10. (2004). Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.
  11. (2004). Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study.
  12. (2009). Erectile dysfunction in systemic sclerosis. Ann Rheum Dis
  13. (1986). HE: Impotence in scleroderma. Ann Intern Med
  14. (1994). Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.
  15. (2010). Masic I: Risk factors for erectile dysfunction in patients with newly diagnosed diabetes mellitus. Med Arh
  16. (2010). Prevalence of erectile dysfunction among Chinese men with type 2 diabetes mellitus.
  17. (2007). Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study.
  18. (2005). S: Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol
  19. (1990). SA: Erectile failure in systemic sclerosis.
  20. (1981). SA: Impotence in progressively systemic sclerosis. Ann Intern Med
  21. (2007). The impact of depression, microvasculopathy, and fibrosis on development of erectile dysfunction in men with systemic sclerosis. Clin Rheumatol
  22. (2006). The penile vasculature in systemic sclerosis: a duplex ultrasound study.
  23. (2003). Vlachoyiannopoulos PG: European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis
  24. (2010). Wespes E: Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.